Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our history
    • Our people
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in review 2018
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • What's happening in each category?
    • PHARMAC's approach to hospital devices
    • Device Advice
    • PHARMAC medical devices forums 2017
  • News
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • One Heart Many Lives
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
  • Pacific
    • Pacific
    • Pacific responsiveness strategy
    • Pacific action plan
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…
  1. About PHARMAC /
  2. Infections - antibacterials

See more about this section

About PHARMAC

  • Your guide to PHARMAC
  • Our history
  • Our people
  • Expert advice
  • PHARMAC's performance
  • Operating policies and procedures
  • Year in review 2018
  • Strategies

About PHARMAC

  • Your guide to PHARMAC
  • Our history
  • Our people
  • Expert advice
  • PHARMAC's performance
  • Operating policies and procedures
  • Year in review 2018
  • Strategies

Infections - antibacterials therapeutic group review

Our role in antimicrobial stewardship

Antibacterials trend 2017

Resistance to antibiotics continues to be a significant source of concern, internationally and in New Zealand.

PHARMAC was part of a cross-agency group of stakeholders, led by the Ministries for Primary Industries and Health, that developed the New Zealand Antimicrobial Resistance Action Plan.

PHARMAC has always supported the responsible use of antimicrobials through various activities including education for health professionals, the Wise Use of Antibiotics campaign, and through our funding decisions. These activities are well aligned with the national Action Plan. We know that providing information to health professionals can make a difference.

We provide prescribers with the evidence-based information needed to do their job. Our contracts for the responsible use of pharmaceuticals are a long-standing initiative to support health professionals in primary care with evidence-based information on prescribing medicines. The services include the provision of educational best practice information on funded pharmaceuticals, tools to encourage debate, reflect on practice and implement change. PHARMAC Seminars are also available.

We have already taken some steps to address concern about growing resistance in secondary care, drawing heavily on advice from our clinical committees.

As part of the work to implement a hospital medicines list in 2013, many of the funded antimicrobials are now accompanied with restrictions on use for stewardship reasons. This has provided secondary care with a framework for prescribing and auditing. All DHB hospitals must comply with the Pharmaceutical Schedule restrictions.

Antibacterials graph 2017

The data on antibiotics

Financial yearAmoxycillinAmoxycillin Clavulanate
CostScriptsCostScripts
Jun-93 $2,967,770.80 432,845 $9,022,492.70 870,465
Jun-94 $3,348,427.60 474,387 $10,819,080.00 1,035,272
Jun-95 $3,785,536.50 529,543 $11,413,923.00 1,075,837
Jun-96 $4,205,985.10 589,539 $12,398,482.00 1,152,591
Jun-97 $4,228,325.90 580,887 $11,734,860.00 1,068,188
Jun-98 $4,120,558.90 706,995 $11,662,751.00 1,097,432
Jun-99 $3,213,432.40 694,503 $10,916,815.00 1,010,105
Jun-00 $3,566,644.20 758,827 $6,958,267.80 763,595
Jun-01 $1,679,167.90 678,023 $4,120,988.70 619,543
Jun-02 $1,019,606.40 692,618 $4,278,821.60 626,561
Jun-03 $942,676.62 662,365 $4,842,393.10 646,686
Jun-04 $958,246.36 656,703 $4,444,564.40 646,701
Jun-05 $1,069,197.50 748,053 $5,076,669.80 730,998
Jun-06 $1,020,475.20 724,160 $5,230,644.30 747,613
Jun-07 $1,123,883.40 802,341 $5,582,631.30 790,836
Jun-08 $1,222,705.90 888,460 $5,630,417.60 795,020
Jun-09 $1,321,238.10 974,675 $5,960,651.10 871,599
Jun-10 $1,338,661.00 980,307 $4,570,479.10 801,854
Jun-11 $1,510,210.70 1,038,638 $4,597,922.50 819,956
Jun-12 $1,597,893.60 1,100,241 $4,438,471.70 822,615
Jun-13 $1,613,062.70 1,162,863 $2,452,549.50 808,525
Jun-14 $1,543,770.70 1,212,005 $2,231,395.60 760,967
Jun-15 $1,389,809.10 1,226,757 $2,008,833.20 778,365
Jun-16 $1,756,525.90 1,382,535 $2,154,855.90 819,590
Jun-17 $1,985,091.60 1,259,730 $2,133,501.40 705,653

 

 

< Infections - antivirals | Cancer medicines >

Last updated: 13 December 2018

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • This site is operated by PHARMAC, the Pharmaceutical Management Agency.

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed

Back to top

New Zealand Government